Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Case report: Lumpy skin disease in an endangered wild banteng (Bos javanicus) and initiation of a vaccination campaign in domestic livestock in Cambodia.
Porco A, Chea S, Sours S, Nou V, Groenenberg M, Agger C, Tum S, Chhuon V, Sorn S, Hong C, Davis B, Davis S, Ken S, Olson SH, Fine AE. Porco A, et al. Among authors: ken s. Front Vet Sci. 2023 Aug 3;10:1228505. doi: 10.3389/fvets.2023.1228505. eCollection 2023. Front Vet Sci. 2023. PMID: 37601751 Free PMC article.
Randomized phase III trial of metabolic imaging-guided dose escalation of radio-chemotherapy in patients with newly diagnosed glioblastoma (SPECTRO GLIO trial).
Laprie A, Noel G, Chaltiel L, Truc G, Sunyach MP, Charissoux M, Magne N, Auberdiac P, Biau J, Ken S, Tensaouti F, Khalifa J, Sidibe I, Roux FE, Vieillevigne L, Catalaa I, Boetto S, Uro-Coste E, Supiot S, Bernier V, Filleron T, Mounier M, Poublanc M, Olivier P, Delord JP, Cohen-Jonathan-Moyal E. Laprie A, et al. Among authors: ken s. Neuro Oncol. 2024 Jan 5;26(1):153-163. doi: 10.1093/neuonc/noad119. Neuro Oncol. 2024. PMID: 37417948 Clinical Trial.
Hypofractionated Stereotactic Re-irradiation and 
Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I Results.
Pouessel D, Ken S, Gouaze-Andersson V, Piram L, Mervoyer A, Larrieu-Ciron D, Cabarrou B, Lusque A, Robert M, Frenel JS, Uro-Coste E, Olivier P, Mounier M, Sabatini U, Sanchez EH, Zouitine M, Berjaoui A, Cohen-Jonathan Moyal E. Pouessel D, et al. Among authors: ken s. Oncologist. 2023 Sep 7;28(9):825-e817. doi: 10.1093/oncolo/oyad095. Oncologist. 2023. PMID: 37196069 Free PMC article. Clinical Trial.
Pseudoprogression in GBM versus true progression in patients with glioblastoma: A multiapproach analysis.
Sidibe I, Tensaouti F, Gilhodes J, Cabarrou B, Filleron T, Desmoulin F, Ken S, Noël G, Truc G, Sunyach MP, Charissoux M, Magné N, Lotterie JA, Roques M, Péran P, Cohen-Jonathan Moyal E, Laprie A. Sidibe I, et al. Among authors: ken s. Radiother Oncol. 2023 Apr;181:109486. doi: 10.1016/j.radonc.2023.109486. Epub 2023 Jan 24. Radiother Oncol. 2023. PMID: 36706959 Clinical Trial.
Quality control of 3D MRSI data in glioblastoma: Can we do without the experts?
Tensaouti F, Desmoulin F, Gilhodes J, Martin E, Ken S, Lotterie JA, Noël G, Truc G, Sunyach MP, Charissoux M, Magné N, Lubrano V, Péran P, Cohen-Jonathan Moyal E, Laprie A. Tensaouti F, et al. Among authors: ken s. Magn Reson Med. 2022 Apr;87(4):1688-1699. doi: 10.1002/mrm.29098. Epub 2021 Nov 26. Magn Reson Med. 2022. PMID: 34825724
37 results